Subscribe To
Head-and-shoulders starting to form on the s&p 500?
This is probably way too premature but the right shoulder of the S&P 500 could start to form if this we...
August 30, 2023, 6:02 pm
Flutter entertainment: high-growth betting and gaming leader winning in the u.s.
Flutter Entertainment is a global sports betting and gaming company with a strong presence in the growing US online sports betting and iGaming market....
August 30, 2023, 12:18 pm
Equinor (eqnr) acquires minority interest in bayou bend project
Bayou Bend supports Equinor's (EQNR) low-carbon solutions portfolio, and its plans to mature and develo...
August 29, 2023, 12:46 pm
Kenya’s equities market rallies on eurobond buy back sentiment
Kenya’s equities and fixed income market is tipped to remain attractive as Kenya’s Eurobond matures...
August 24, 2023, 3:59 pm
Enterprise products partners: the highest-quality 8%-yielding wide moat mlp
Enterprise Products Partners is a top-tier midstream company in the energy sector. EPD will benefit from rising energy production, higher export deman...
August 24, 2023, 7:00 am
Gilead, arcus, iteos, other biopharmas get boost from accidental disclosure of roche lung cancer trial data
Shares of biopharmaceutical companies developing anti-TIGIT cancer therapies, including Gilead Sciences Inc. GILD, +0.54%, Arcus Biosciences Inc. RCUS...
August 23, 2023, 8:45 am
Dow futures (ym_f) looking for corrective rally soon
Short Term Elliott Wave view in Dow Futures (YM_F) suggests that cycle from 7.27.2023 high is mature an...
August 23, 2023, 7:00 am
Vnq etf: i'm building my own market-beating etf
The Vanguard Real Estate ETF is the largest real estate ETF in the world, but its performance has been poor compared to other ETFs. Rising interest ra...
August 22, 2023, 11:00 am
Alibaba: meltdown fears have returned - that's why i'm buying more
Alibaba stock's post-earnings sizzle is gone, as investors sold out of Chinese stocks in a hurry as they prepare for a meltdown in China's property ma...
August 19, 2023, 8:30 am
Valeura energy: an explosive option on oil as its journey unfolds
Valeura Energy has made successful operational progress following its acquisitions of mature oil-produc...
August 14, 2023, 6:27 pm
Elon musk vs. mark zuckerberg: the stupidest story of the summer appears over
Mark Zuckerberg, billionaire and chief executive of Meta Platforms Inc. META, -1.34%, on Sunday appeared to pull the grown-up card — or at least the...
August 13, 2023, 5:03 pm
Fed's daly: cpi data was as expected, it's good news for families and businesses
We are committed to getting core inflation downThere's a lot more info coming in beforeI see slowing in the economy but we're not there yetIt's still ...
August 10, 2023, 3:06 pm
Here's why cash cow etfs are soaring to new highs
The appeal for cash cows is back, given the stock market volatility and uncertainty. A cash cow is a company or a business unit in a ...
August 10, 2023, 1:01 pm
Two dividend aristocrats with unappreciated ai upside
Artificial Intelligence (AI) is generating a lot of hype on Wall Street, with investors eager to capitalize on its potential. Companies that have been...
August 3, 2023, 3:33 am
Boj deputy governor uchida: japan needs to maintain easy policy
BOJ Deputy Governor Uchida: At present, risk of losing chance to hit price target with premature shift ...
August 2, 2023, 1:35 am
Amgen (amgn) to report q2 earnings: here's what to expect
Volume growth from Amgen's (AMGN) key drugs like Prolia, Repatha and Evenity, among others, is expected to have been partially offset by biosimilar/ge...
July 31, 2023, 12:38 pm
This presidential hopeful is a big bitcoin supporter
As is the case with many asset classes as they mature, bitcoin has drawn more political attention – b...
July 28, 2023, 9:18 am
Ecb's kazimir: premature to consider a september pause the end of the tightening cycle
We should take a firm step further on our way to the topEven if we do take a break in September, it would be pre...
July 28, 2023, 9:07 am
Relay therapeutics: market may be prematurely dismissing rly-2608
Relay Therapeutics' early clinical data for cancer drug RLY-2608 sparked investor concerns due to lack of robust evidence of efficacy, leading to a 40...
July 28, 2023, 6:04 am
Mj and msos: likely no immediate reprieve
The marijuana industry has not rewarded patient investors as expected, even five years after Canadian legalization and despite hopes for federal legal...
July 26, 2023, 1:36 pm